Akademska digitalna zbirka SLovenije - logo
E-viri
Recenzirano Odprti dostop
  • Chimeric Antigen Receptor T...
    Schuster, Stephen J; Svoboda, Jakub; Chong, Elise A; Nasta, Sunita D; Mato, Anthony R; Anak, Özlem; Brogdon, Jennifer L; Pruteanu-Malinici, Iulian; Bhoj, Vijay; Landsburg, Daniel; Wasik, Mariusz; Levine, Bruce L; Lacey, Simon F; Melenhorst, Jan J; Porter, David L; June, Carl H

    The New England journal of medicine, 12/2017, Letnik: 377, Številka: 26
    Journal Article

    Among 38 patients with refractory diffuse large B-cell lymphoma or follicular lymphoma, 28 were able to receive CAR T cells; 16 had complete remission, and none of those who had had a complete response at 6 months had a relapse at 28 months of follow-up.